Locations:
Search
The rare condition can cause structural damage if untreated
Cleveland Clinic specialists discuss challenges and opportunities for managing the disease
Cleveland Clinic and Johns Hopkins collaboration could help meet need for new therapies
Is it time to innovate?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multicenter effort aims to standardize information about diagnosis and early management
Recognizing mobility as a human right is instrumental to change
Findings from more than 7,500 donor-recipient pairs
Increasing support for breastfeeding patients
Variables affect nuances of the conversation
First in-human trial using CRISPR/CASP 12 for gene editing in sickle cell disease
Advertisement
Advertisement